LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Women with HIV Frequently Pass CMV to Infant

By LabMedica International staff writers
Posted on 05 Jul 2017
Print article
Image: Cytomegalovirus. According to a new study, HIV-positive women with cytomegalovirus (CMV) in their urine at the time of labor and delivery are over five times likelier to transmit HIV than HIV-positive women without CMV (Photo courtesy of the CDC).
Image: Cytomegalovirus. According to a new study, HIV-positive women with cytomegalovirus (CMV) in their urine at the time of labor and delivery are over five times likelier to transmit HIV than HIV-positive women without CMV (Photo courtesy of the CDC).
Cytomegalovirus (CMV) can impair fetal growth, and babies born with the virus can have damage to the brain, liver, lung and spleen, as well as hearing loss.

People who are otherwise healthy usually do not experience any symptoms, but it can cause fever, sore throat, fatigue and swollen glands. In people with compromised immune systems, however, CMV can affect the eyes, lungs, liver, esophagus, stomach and intestines.

An international team of scientists led by those at University of California, Los Angeles (CA, USA) evaluated cytomegalovirus (CMV) urinary shedding in pregnant women infected with human immunodeficiency virus (HIV) to determine whether it poses an increased risk for congenital CMV infection (cCMV). They evaluated 260 pairs of mothers and infants, 222 from the Americas and 38 from South Africa, who were enrolled in a perinatal study. Maternal and infant urines were tested by qualitative real-time polymerase chain reaction (RT-PCR) for CMV DNA with quantitative RT-PCR performed on positive specimens.

The investigators found that 24 women (9.2%) had detectable CMV viruria by qualitative PCR. Maternal CMV viruria was not associated with mean CD4 cell counts or HIV viral load but was associated with younger maternal age. Overall, 10 of 260 infants (3.8%) had cCMV and women with detectable peripartum CMV viruria were more likely to have infants with cCMV than those without. HIV-positive women with CMV in their urine at the time of labor and delivery are more than five times likelier than HIV-positive women without CMV to transmit HIV to their infants. The study also found that they are nearly 30 times likelier to transmit CMV to their infants. Maternal gonorrhea and higher maternal HIV log10 viral load were also significant risk factors for cCMV.

The authors concluded that HIV-infected pregnant women not on antiretrovirals, urinary CMV shedding was a significant risk factor for CMV and HIV transmission to infants. Karin Nielsen-Saines, MD, MPH, a professor of clinical pediatrics, and senior author of the study, said, “The findings were surprising because prior studies in healthy pregnant women have not shown an association between CMV detection in urine, or even cervical secretions, and congenital CMV infection.” The study was published on June 21, 2017, in the journal Clinical Infectious Diseases.

Related Links:
University of California, Los Angeles

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.